Following the four Excelsior Awards from National Innovation Awards in 2022, FEMH was honored yet again with four Excelsior Awards for innovations in academic research and two additional awards for innovative excellence in 2023. The winning projects span across AI, precision testing and innovative surgical technologies, demonstrating excellence in academic research and clinical development, and providing quality care to patients with a multitude of treatment options.

AI-powered Healthcare Revolution

FEMH utilizes AI, big data as well as machine learning and prediction to address the shortcomings regarding manual assessment and classification of burn area and depth. The hospital also optimized medical image analysis and lesion detection to provide the best medical treatment and shorten the detection time. The three award-winning projects related to AI are “One-stop CT Myocardial Perfusion Imaging in the Evaluation of Patients with Severe Coronary Artery Stenosis;” “AI-powered Burn Diagnosis Platform and Software;” “AI-assisted Automatic Meningioma and Acoustic Neuroma Detection System.”

Early Dementia Diagnosis with Innovative Biomarkers

FEMH uses amyloid T-cell responses as innovative biomarkers for cognitive impairment, which identify patients with mild cognitive impairment with higher precision than p-Tau181, the biomarker approved by the U.S. Food and Drug Administration, thus receiving the Excelsior Award.

A New Era for Spine Surgery with UBE

The two projects receiving the Excelsior Awards for innovative excellence are “The Application and Development of Unilateral Biportal Endoscopic (UBE) Spine Techniques in Spine Surgeries” and “Fast Navigation and Smart Screw Implant System for Spine Surgery in Hybrid Operating Room,” which have ushered in a new era for spine surgeries. Since 2018, FEMH has performed over 1,000 UBE surgeries with multiple papers published in academic journals. The injection device and bone chisel also received authorization for technology transfer, attracting medical doctors from home and abroad to further their study at FEMH. In addition, the hospital developed the hybrid surgical navigation system with biomedical companies and has received patent approval.